Diagnostic Investigation and Prediction of Shock (DiPS)
Diagnostic Investigation and Prediction of Shock (The DiPS Study)
Background to the research Patients present to Emergency Departments (ED) with a spectrum of illness, many of which are life- threatening. The body has the ability to compensate in the early stages when things go wrong so that on the surface patients do not appear as sick as they really are. Under-diagnosis of severity of illness leads to under-treatment, unnecessary mortality, and unnecessary hospital costs. Earlier diagnosis and consequent treatment will result in prudent healthcare, cost-benefit and better patient outcomes.
Evaluating the true underlying patient haemodynamics such as cardiac output, cardiac power and peripheral pressures gives vital clues to the hidden seriousness of illness and is a guide to better management. Few EDs in the world assess such haemodynamics. After evaluating a haemodynamic protocol one centre in Australia was able to reduce its death rate for septic shock at 30 days from 38% to 7%. We would like to evaluate whether the same would occur if applied across EDs in Wales. However, before we can do that we need to strengthen our understanding of haemodynamics, and of relevant protocols and non-invasive devices that help us to acquire such information.
Study Design After ethics and institutional approval is obtained from we will conduct a prospective, single-centre, cohort study on 354 adult patients with possible shock associated with an acute illness or injury who present to the Emergency Department of the University Hospital of Wales, and follow them up for 7 days. 354 is a credible number to confirm that the strategy works.
Written consent will be obtained either from the patient or a relative wherever possible but a waiver of consent apply to patients who, because of confusion, unconsciousness or severe disability, may be unable to give consent. In these cases, consent will first be sought from a second doctor and/or nurse. Thereafter, consent will be obtained from the patient or a relative as soon as practically possible.
What you hope to discover
We expect to discover that:
- Uscom variables predict 7-day survival and ICU admission
- Uscom variables improve the detection and classification of shock
- The LiPS definition can be improved.
- The objective definition is better than doctors experience
- Patients have a good experience and are satisfied with care
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Patients frequently present to emergency departments (EDs) with critical illness and injury. Shock is a life-threatening emergency, which requires urgent and rapid assessment, diagnosis and treatment, and can be classified into distributive-septic (62%), distributive-non-septic (4%), hypovolaemic (16%), cardiogenic (16%) and obstructive (2%). Sepsis is the leading cause of in-hospital death, and approximately 80% of these patients are admitted through the ED. In Chinese patients presenting to an ED in Hong Kong we have previously derived and validated a simple, a priori, pragmatic, quantitative method for recognising and classifying shock - Li's Practical Shock (LiPS) tool. This method has been validated against ICU admission and early mortality. However, it was derived in a single population in a single centre, and requires further validation and refined in other settings. Further, it does not sub-classify patients beyond 'normal, cold and warm shock', does not guide next steps in treatment, and the assessment of the peripheries is very subjective.
Evaluating the true underlying patient haemodynamics such as cardiac output, cardiac power and peripheral pressures gives vital clues to the hidden seriousness of illness and is a guide to better management. Few EDs in the world assess such haemodynamics. After evaluating a haemodynamic protocol one centre in Australia was able to reduce its death rate for septic shock at 30 days from 38% to 7%. We would like to evaluate whether the same would occur if applied across EDs in Wales. However, before we can do that we need to strengthen our understanding of haemodynamics, and of relevant protocols and non-invasive devices that help us to acquire such information.
There are many unanswered questions such as:
- Do Uscom-derived haemodynamic variables measured in the ED predict patients who at high risk of death, admission to ICU, and have shock?
- Does a refined LiPS definition better predict mortality and ICU admission?
- Do advanced haemodynamic predictors and/or refined LiPS predict better than experienced physicians the presence and classification of patients with shock, mortality and ICU admission?
This study will answer two main questions:
- What is the probability that a patient has shock?
- What type of shock does the patient have?
We propose:
- To investigate whether advanced haemodynamic variables using USCOM predict 7-day mortality and ICU admission.
- To investigate whether advanced haemodynamic variables using USCOM improve the detection and classification of shock.
- To validate and refine Li's a priori Pragmatic Shock (LiPS) method for detecting and classifying shock.
- To evaluate clinical experience for shock.
- To inform on the feasibility of future studies
After ethics and institutional approval is obtained from we will conduct a prospective, single-centre, cohort study on 354 adult patients with possible shock associated with an acute illness or injury who present to the Emergency Department of the University Hospital of Wales, and follow them up for 7 days. 354 is a credible number to confirm that the strategy works.
Written consent will be obtained either from the patient or a relative wherever possible but a waiver of consent apply to patients who, because of confusion, unconsciousness or severe disability, may be unable to give consent. In these cases, consent will first be sought from a second doctor and/or nurse. Thereafter, consent will be obtained from the patient or a relative as soon as practically possible.
The challenge is to discover a strategy that has a sensitivity >67% and specificity >72% for determining in-hospital mortality in clinically deteriorating or potentially shocked patients.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
S Glamorgan
-
Cardiff, S Glamorgan, United Kingdom, CF14 4XN
- Cardiff University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients aged ≥18 years
- a NEWS≥3,
- requiring a trolley
Exclusion Criteria:
• <18 years
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite of ICCU/all cause mortality
Time Frame: 7 days
|
Number of patients with admission to either ICU, or CCU, or death from any cause
|
7 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
In-hospital mortality
Time Frame: 28 days
|
Number of patients with death from any cause in hospital
|
28 days
|
|
28-day mortality
Time Frame: 28 days
|
Number of patients with death from any cause within 28 days
|
28 days
|
|
Admission to ICCU
Time Frame: 7 days
|
Number of patients with admission to either ICU or CCU
|
7 days
|
|
ED shock
Time Frame: Within 4 hours of ED arrival
|
Number of patients with shock in the ED defined according to LiPS criteria
|
Within 4 hours of ED arrival
|
|
Types of ED Shock
Time Frame: Within 4 hours of ED arrival
|
Number of patients with ED shock categorised as either primarily restrictive or hypovolaemic, or cardiogenic or obstructive shock.
|
Within 4 hours of ED arrival
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility variables
Time Frame: 4 hours
|
patient acceptance and experience, medical and nursing acceptance and experience, and evaluation of the infrastructure necessary to perform future definitive randomised controlled trials of this type in the emergency setting, to inform on sample sizes for future studies, to assess the processes and workload involved in patient recruitment, consent and reasons for non-participation, and to assess the potential loss to follow up and impact on analysis and interpretation
|
4 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Timothy H Rainer, MD, Professor of Emergency Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CardiffU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shock
-
NCT06270615CompletedWounds and Injuries | Hemorrhagic Shock | Traumatic Shock
-
NCT02971670CompletedSepsis | Toxic-Shock Syndrome
-
NCT02111109Completed
-
NCT02924792CompletedHemorrhagic Shock | Hypovolemic Shock
-
NCT03477006Terminated
-
NCT00973102Completed
-
NCT03038503UnknownSeptic Shock | Refractory Shock
-
NCT03235921Unknown
Clinical Trials on Ultrasound Cardiac Output Monitor
-
NCT01309724Completed
-
NCT02083172CompletedCritical Illness | Hemodynamically Stable
-
NCT04064177RecruitingBlood Pressure | Cardiac Output, Low | Cardiac Output, High
-
NCT06240104RecruitingMyocardial Ischaemia During Surgery
-
NCT01184430UnknownPostoperative Wound Infection | Postoperative Outcome
-
NCT01877941CompletedMyocardial Infarction | Myocardial Ischemia
-
NCT07092644RecruitingCongenital Heart Disease
-
NCT02951104CompletedPulmonary Hypertension
-
NCT03525743Completed